Effect of Subcutaneous Recombinant Human Erythropoetin in Cancer Patients Receiving Radiotherapy: Final Report of a Randomized, Open-Labelled, Phase II Trial

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1998.331
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search